birb 796 has been researched along with mart-1 antigen in 1 studies
Studies (birb 796) | Trials (birb 796) | Recent Studies (post-2010) (birb 796) | Studies (mart-1 antigen) | Trials (mart-1 antigen) | Recent Studies (post-2010) (mart-1 antigen) |
---|---|---|---|---|---|
137 | 5 | 80 | 1,241 | 99 | 446 |
Protein | Taxonomy | birb 796 (IC50) | mart-1 antigen (IC50) |
---|---|---|---|
HLA class I histocompatibility antigen, A alpha chain | Homo sapiens (human) | 0.2624 | |
5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.2624 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.2624 | |
5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.2624 | |
Gastrin/cholecystokinin type B receptor | Homo sapiens (human) | 0.2624 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, S; Du, L; Han, X; Hu, C; Jin, A; Li, L; Li, S; Pang, D; Shen, M; Tao, K; Wang, W; Zhang, J | 1 |
1 other study(ies) available for birb 796 and mart-1 antigen
Article | Year |
---|---|
p38 inhibition enhances TCR-T cell function and antagonizes the immunosuppressive activity of TGF-β.
Topics: Cell Line; Genetic Engineering; Granzymes; Humans; Immune Tolerance; Immunotherapy, Adoptive; Interferon-gamma; Lymphocyte Activation; MART-1 Antigen; Naphthalenes; p38 Mitogen-Activated Protein Kinases; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrazoles; Receptors, Antigen, T-Cell; T-Lymphocytes; Transforming Growth Factor beta | 2021 |